Logo image of VCRA

VOCERA COMMUNICATIONS INC (VCRA) Stock Fundamental Analysis

NYSE:VCRA - New York Stock Exchange, Inc. - Common Stock

79.13  -0.04 (-0.05%)

After market: 79.13 0 (0%)

Fundamental Rating

2

Overall VCRA gets a fundamental rating of 2 out of 10. We evaluated VCRA against 35 industry peers in the Health Care Technology industry. VCRA may be in some trouble as it scores bad on both profitability and health. VCRA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VCRA had positive earnings in the past year.
VCRA Yearly Net Income VS EBIT VS OCF VS FCFVCRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M 20M

1.2 Ratios

Industry RankSector Rank
ROA -1.53%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VCRA Yearly ROA, ROE, ROICVCRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10 -15

1.3 Margins

Industry RankSector Rank
OM 0.27%
PM (TTM) -3.63%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VCRA Yearly Profit, Operating, Gross MarginsVCRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, VCRA has more shares outstanding
The debt/assets ratio for VCRA is higher compared to a year ago.
VCRA Yearly Shares OutstandingVCRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
VCRA Yearly Total Debt VS Total AssetsVCRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

2.2 Solvency

VCRA has an Altman-Z score of 5.10. This indicates that VCRA is financially healthy and has little risk of bankruptcy at the moment.
VCRA has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 5.1
ROIC/WACCN/A
WACCN/A
VCRA Yearly LT Debt VS Equity VS FCFVCRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.68 indicates that VCRA has no problem at all paying its short term obligations.
VCRA has a Quick Ratio of 2.64. This indicates that VCRA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.64
VCRA Yearly Current Assets VS Current LiabilitesVCRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

VCRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.27%, which is quite impressive.
Measured over the past years, VCRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 63.18% on average per year.
The Revenue has grown by 18.02% in the past year. This is quite good.
VCRA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.15% yearly.
EPS 1Y (TTM)47.27%
EPS 3Y16.67%
EPS 5Y63.18%
EPS Q2Q%3.57%
Revenue 1Y (TTM)18.02%
Revenue growth 3Y9.25%
Revenue growth 5Y12.15%
Sales Q2Q%16.22%

3.2 Future

The Earnings Per Share is expected to grow by 17.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 12.44% on average over the next years. This is quite good.
EPS Next Y5.31%
EPS Next 2Y14.03%
EPS Next 3Y15.86%
EPS Next 5Y17.63%
Revenue Next Year11.38%
Revenue Next 2Y12.99%
Revenue Next 3Y12.25%
Revenue Next 5Y12.44%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VCRA Yearly Revenue VS EstimatesVCRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
VCRA Yearly EPS VS EstimatesVCRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VCRA is valuated quite expensively with a Price/Earnings ratio of 97.69.
Compared to an average S&P500 Price/Earnings ratio of 26.82, VCRA is valued quite expensively.
A Price/Forward Earnings ratio of 92.77 indicates a quite expensive valuation of VCRA.
VCRA is valuated expensively when we compare the Price/Forward Earnings ratio to 35.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 97.69
Fwd PE 92.77
VCRA Price Earnings VS Forward Price EarningsVCRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 268.71
VCRA Per share dataVCRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as VCRA's earnings are expected to grow with 15.86% in the coming years.
PEG (NY)18.41
PEG (5Y)1.55
EPS Next 2Y14.03%
EPS Next 3Y15.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VCRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VOCERA COMMUNICATIONS INC

NYSE:VCRA (2/22/2022, 8:18:09 PM)

After market: 79.13 0 (0%)

79.13

-0.04 (-0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-10 2022-02-10
Earnings (Next)04-27 2022-04-27
Inst Owners0%
Inst Owner Change0%
Ins Owners2.75%
Ins Owner Change0%
Market Cap2.75B
Analysts71.25
Price Target80.91 (2.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 97.69
Fwd PE 92.77
P/S 11.76
P/FCF N/A
P/OCF N/A
P/B 16.99
P/tB N/A
EV/EBITDA 268.71
EPS(TTM)0.81
EY1.02%
EPS(NY)0.85
Fwd EY1.08%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.73
BVpS4.66
TBVpSN/A
PEG (NY)18.41
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA -1.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.27%
PM (TTM) -3.63%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.68
Quick Ratio 2.64
Altman-Z 5.1
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.27%
EPS 3Y16.67%
EPS 5Y63.18%
EPS Q2Q%3.57%
EPS Next Y5.31%
EPS Next 2Y14.03%
EPS Next 3Y15.86%
EPS Next 5Y17.63%
Revenue 1Y (TTM)18.02%
Revenue growth 3Y9.25%
Revenue growth 5Y12.15%
Sales Q2Q%16.22%
Revenue Next Year11.38%
Revenue Next 2Y12.99%
Revenue Next 3Y12.25%
Revenue Next 5Y12.44%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A